EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

A Systematic Review on the Combination of Glipizide and Metformin for Type Two Diabetes

Lakshmi Nagendra, Khushboo Agarwal, Akhila Panduranga Bhandarkar, Ajay Hanumanthu, R. Anantharaman, Abhamoni Baro, Parth Jethwani, Saptarshi Bhattacharya, Nitin Kapoor, Sanjay Kalra, Aneesha Gupta, Rohan N. Kesarkar und 1 weitere

Chronicle of Diabetes Research and Practice · 2026-07 · 5 (2) · 87-97

DOI: 10.4103/cdrp.cdrp_26_25 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Chronicle of Diabetes Research and Practice, online erschienen am 17.07.2026. Verfasst von Lakshmi Nagendra und 12 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Type 2 diabetes mellitus (T2DM) is a chronic and complex metabolic disorder that requires a combination of lifestyle modifications and pharmacological therapies to delay disease-related complications and maintain overall quality of life. This review seeks to systematically evaluate and consolidate the available evidence on clinical effectiveness and safety profile of the glipizide–metformin combination in adults with T2DM.

Methods

This review included randomized controlled trials (RCTs), observational, and real-world studies assessing the efficacy and safety of glipizide–metformin combination therapy in adults (≥18 years) with T2DM. Included studies assessed glycemic control, hypoglycemia, weight change, and safety versus placebo, monotherapy, or other oral agents, and were published in English. A literature search was performed in PubMed using appropriate keywords and Medical Subject Headings terms.

Results

A total of 12 studies were included in this systematic review. Patients included in these studies were over 50 years old, with ages ranging from 53.5 to 62.8 years. Across eight RCTs the glipizide–metformin combination demonstrated a reduction in glycated hemoglobin (HbA1c) of approximately 0.5–0.8%, accompanied by minimal weight gain. The proportion of patients achieving HbA1c

Zitieren

APA

Nagendra, L., Agarwal, K., Bhandarkar, A. P., Hanumanthu, A., Anantharaman, R., Baro, A., Jethwani, P., Bhattacharya, S., Kapoor, N., Kalra, S., Gupta, A., Kesarkar, R. N., & Pednekar, A. (2026). A Systematic Review on the Combination of Glipizide and Metformin for Type Two Diabetes. Chronicle of Diabetes Research and Practice, 5(2), 87-97. https://doi.org/10.4103/cdrp.cdrp_26_25

Vancouver

Nagendra L, Agarwal K, Bhandarkar AP, Hanumanthu A, Anantharaman R, Baro A, et al. A Systematic Review on the Combination of Glipizide and Metformin for Type Two Diabetes. Chronicle of Diabetes Research and Practice. 2026;5(2):87-97. doi:10.4103/cdrp.cdrp_26_25

BibTeX
@article{Nagendra2026,
  author = {Nagendra, Lakshmi and Agarwal, Khushboo and Bhandarkar, Akhila Panduranga and Hanumanthu, Ajay and Anantharaman, R. and Baro, Abhamoni and Jethwani, Parth and Bhattacharya, Saptarshi and Kapoor, Nitin and Kalra, Sanjay and Gupta, Aneesha and Kesarkar, Rohan N. and Pednekar, Abhijit},
  title = {A Systematic Review on the Combination of Glipizide and Metformin for Type Two Diabetes},
  journal = {Chronicle of Diabetes Research and Practice},
  year = {2026},
  volume = {5},
  number = {2},
  pages = {87--97},
  doi = {10.4103/cdrp.cdrp_26_25}
}
Kostenlos starten →